Suppr超能文献

[腹腔镜下低位直肠癌部分、次全及全括约肌间切除术的肿瘤学结局与肛门功能比较]

[Comparison of oncology outcomes and anal function among laparoscopic partial, subtotal and total intersphincteric resection for low rectal cancers].

作者信息

Zhang Bin, Liu Quanlong, Zhao Yujuan, Zhuo Guangzuan, Yin Shuhui, Zhu Jun, Zhao Ke, Ding Jianhua

机构信息

Department of Colo-Rectal Disease Surgery, The General Hospital of the PLA Rocket Force, Beijing 100088, China.

出版信息

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Aug 25;20(8):904-909.

Abstract

OBJECTIVE

To compare the oncology outcomes and anal function among laparoscopic partial, subtotal and total intersphincteric resection(ISR) for low rectal cancers.

METHODS

From June 2011 to February 2016, a total of 79 consecutive patients with low rectal cancers underwent laparoscopic ISR with hand-sewn coloanal anastomosis at our department. According to the distal tumor margin, partial ISR (internal sphincter resection at the dentate line) was used to treat tumors with distance <1 cm from the anal sphincter (n=28), subtotal ISR was adopted for the tumors locating between the dentate line and intersphincteric groove (n=34), and total ISR (resection at the dentate line) was applied in the treatment of intra-anal tumors (n=17). Anal function was evaluated by a standardized gastrointestinal questionnaire, Wexner incontinence score and Kirwan's classification. Metaphase oncological results and postoperative anal function were compared among three groups, and.

RESULTS

Other than the distance of tumor low margin to dentate line (P=0.000) and serum CEA level (P=0.040), no significant differences were noted in baseline data among 3 groups (all P>0.05). The median follow up was 21(8-61) months. The 3-year disease-free survival rates in laparoscopic partial, subtotal and total ISR groups were 91.1%, 88.9%, 88.2% (P=0.901) and the 3-year local relapse-free survival rates were 91.1%, 72.9%, 80.2%(P=0.658), whose all differences were not significant. Thirty-eight patients who did not receive neoadjuvant chemoradiotherapy and underwent ileostomy closure for at least 24 months completed the evaluation of anal function, including 14 cases in partial group, 15 cases in subtotal group and 9 cases in total group. Of 38 patients, 73.7%(28/38) was classified as good function (Wexner incontinence score ≤10) and no patient adopted a colostomy because of severe fecal incontinence(Kirwan classification=grade 5). Furthermore, there were no significant differences in Wexner incontinence score and Kirwan classification among 3 groups (all P>0.05). However, patients with chronic anastomotic stoma stenosis showed worse anal function than those without stenosis [Wexner incontinence score: 18(9-20) vs 6(0-18), P=0.000; Kirwan grading: 3(2-4) vs. 2(1-4), P=0.002].

CONCLUSIONS

As the ultimate sphincter-saving technique, laparoscopic ISR can result in better oncologic outcomes and better anal function for patients with low rectal cancers. The different procedures of ISR may not affect the efficacy, but chronic anastomotic stoma stenosis deteriorates incontinence status.

摘要

目的

比较腹腔镜下低位直肠癌部分、次全及全括约肌间切除术(ISR)的肿瘤学结局及肛门功能。

方法

2011年6月至2016年2月,我院共有79例低位直肠癌患者接受了腹腔镜ISR及手工缝合结肠肛管吻合术。根据肿瘤远端切缘,距肛门括约肌<1 cm的肿瘤采用部分ISR(齿状线处内括约肌切除术)治疗(n = 28),位于齿状线与括约肌间沟之间的肿瘤采用次全ISR(n = 34),肛管内肿瘤采用全ISR(齿状线处切除术)治疗(n = 17)。采用标准化胃肠问卷、Wexner失禁评分和Kirwan分类法评估肛门功能。比较三组患者的中期肿瘤学结局及术后肛门功能。

结果

除肿瘤下缘距齿状线的距离(P = 0.000)和血清CEA水平(P = 0.040)外,三组患者的基线数据无显著差异(均P>0.05)。中位随访时间为21(8 - 61)个月。腹腔镜部分、次全及全ISR组的3年无病生存率分别为91.1%、88.9%、88.2%(P = 0.901),3年局部无复发生存率分别为91.1%、72.9%、80.2%(P = 0.658),差异均无统计学意义。38例未接受新辅助放化疗且回肠造口关闭至少24个月的患者完成了肛门功能评估,其中部分组14例,次全组15例,全组9例。38例患者中,73.7%(28/38)的肛门功能良好(Wexner失禁评分≤10),无患者因严重大便失禁(Kirwan分类 = 5级)而采用结肠造口术。此外,三组患者的Wexner失禁评分和Kirwan分类无显著差异(均P>0.05)。然而,慢性吻合口狭窄患者的肛门功能较无狭窄患者差[Wexner失禁评分:18(9 - 20)对6(0 - 18),P = 0.000;Kirwan分级:3(2 - 4)对2(1 - 4),P = 0.002]。

结论

作为最终的保括约肌技术,腹腔镜ISR可为低位直肠癌患者带来更好的肿瘤学结局及肛门功能。不同的ISR手术方式可能不影响疗效,但慢性吻合口狭窄会使失禁状况恶化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验